Publications
- Oral cladribine in the treatment of multiple sclerosis - data from the national registry ReMuS(R) registry2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Effectiveness of natalizumab extended interval dosing in multiple sclerosis patients2020 | Second Faculty of Medicine
- Interferons-β treatment during pregnancy and breast-feeding2020 | Second Faculty of Medicine
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- Biomarkers of disease course and prognosis in multiple sclerosis patients2018 | Second Faculty of Medicine
- Myxovirus resistance protein A in interferon-β therapy in patients with multiple sclerosis and treatment effectiveness monitoring algorithm2016 | First Faculty of Medicine, Second Faculty of Medicine
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Neutralising antibodies and Myxovirus resistance protein A as a marker of biological response to interferon β2014 | Second Faculty of Medicine
- Interpretation of neutralizing antibodies and myxovirus resitance protein A testing in patients with multiple sclerosis treated with interferon beta2014 | Second Faculty of Medicine
- Multiple sclerosis2013 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...